Invitrogen Posts 10 Percent Q1 Revenue Gain as Cell-Culture Segment Rebounds | GenomeWeb
This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
Invitrogen this week reported that its first-quarter revenues increased 10 percent year over year, with its Cell Culture Systems unit rebounding, due partially to the sale of the struggling BioReliance business during the quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.